Zacks Research Expects Lower Earnings for Eastman Chemical

robot
Abstract generation in progress

Zacks Research has lowered its Q3 2026 EPS estimate for Eastman Chemical (NYSE: EMN) to $1.64 from $1.68, maintaining a “Hold” rating on the stock. The company recently reported Q4 earnings of $0.75 per share, missing consensus estimates by $0.01, with a 12.1% year-over-year revenue decline. Eastman Chemical also declared a quarterly dividend of $0.84, offering a 4.8% yield.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin